$
2. 45
+0.23
+10.3604%
$
37.49M Market Cap
- P/E Ratio
- Div Yield
74,444 Volume
- Eps
$ 2.22
Previous Close Investors:
Want to track SER and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Serina Therapeutics Inc. (SER) Statistics
Valuation metrics
Market Cap 37.49M
Enterprise value 13.48M
Trailing P/E (ttm) -1.18
Forward P/E -
PEG ratio 0.03
Price/Sales (ttm) 200
Price/Book (mrq) 1.94
Enterprise Value/Revenue 35.72
Enterprise Value/EBITDA -0.61
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 69.3K
Average volume (90 days) 46.85K
Price summary
52-Week low 1.22
52-Week high 5.83
Beta -
50-Day moving average 2.27
200-Day moving average 1.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -0.12
Dividend Date -
Ex-Dividend Date -
Last split factor 28:1,000
Last split Date 15 Mar 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -163.59%
Operating margin -188.03%
Operational effectiveness
Return on assets -0.82%
Return on equity -2.22%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.41
Total debt (mrq) -
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 6.65%
Book value per share (mrq) 1.14
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
